Mission Therapeutics's last reported valuation, Mar 2024. Nothing priced has surfaced since.
- ·The complete investor list: 17 names
- ·Watch Mission Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Mission Therapeutics funding history
No funding rounds for Mission Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Mission Therapeutics valuation
Mission Therapeutics's last reported valuation was $115 million in Mar 2024. No priced round, secondary trade or fund mark has surfaced since.
How Mission Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Mission Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about Mission Therapeutics
- What is Mission Therapeutics worth?
- Mission Therapeutics is valued at $115.2M as of Oct 2026. Mission Therapeutics's last reported valuation, Mar 2024. Nothing priced has surfaced since.
- How much has Mission Therapeutics raised?
- Mission Therapeutics has raised $213.8M in total funding across its recorded rounds.